Pinnbrook Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.55M Buy
46,098
+22,818
+98% +$2.63M 1.44% 19
2025
Q4
$2.45M Buy
23,280
+11,355
+95% +$1.07M 0.34% 78
2025
Q3
$1M Buy
+11,925
New +$982K 0.11% 131

Other funds holding MRK

Pinnbrook Capital Management's MRK Position: Q1 2026 in Review

Pinnbrook Capital Management increased its Merck (MRK) stake by 98% in Q1 2026, buying an estimated $2.63M and bringing the position to 46,098 shares worth $5.55M. The position accounts for 1.44% of the portfolio, ranked #19.

Pinnbrook Capital Management first reported a position in MRK in Q3 2025 and has held it in 3 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Pinnbrook Capital Management held 46,098 shares of Merck worth $5.55M as of Q1 2026.
  • Pinnbrook Capital Management bought 22,818 Merck shares in Q1 2026, an estimated $2.63M.
  • Merck made up 1.44% of Pinnbrook Capital Management's portfolio in Q1 2026, its #19 holding.
  • Pinnbrook Capital Management first reported a position in Merck in Q3 2025 and has held it in 3 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Pinnbrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.